...
首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy
【24h】

Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy

机译:药物洗脱支架在分叉冠状动脉病变中的长期结果,应用系统的治疗策略

获取原文
获取原文并翻译 | 示例

摘要

Objectives: To explore the long-term results following implantation of drug-eluting stents (DES) in bifurcation lesions according to contemporary "real world" practice. Background: Limited information is available on the long-term outcomes of patients with bifurcation lesions who are treated using DES. A systematic approach for bifurcation lesion management was applied, using either a "provisional" single stent technique or a dedicated two stents strategy according to the side-branch diameter and severity of its ostial stenosis. Methods: Four hundred one consecutive patients underwent bifurcation percutaneous coronary intervention (PCI) using DES and were included in our prospective registry. All adverse events were recorded up to 2 years and distinguished according to the planned PCI strategy (e.g., one versus two stents technique). Results: A planned two stents strategy was used in 141 patients (35% of patients). In 260 patients (65%), the planned treatment involved stenting of the main branch only with "provisional" stenting of the side-branch according to procedural course. Thus, 24 patients (9.2%) needed additional stenting at the side-branch to complete the PCI. Cumulative major adverse cardiac event rate at 1 and 2 years was similar for both groups (11.4% vs. 14.8% at 1 year and 19.4% vs. 25.7% at 2 years for the single vs. two stents groups, accordingly, P = NS for both). Likewise, there was no difference in mortality, cardiac mortality, myocardial infarction, need for target lesions or target vessel revascularization, or definite stent thrombosis rate between the two groups at 6, 12, and 2 years follow-up. The rate of angiographically confirmed (i.e., definite) stent thrombosis did not differ between the two groups during follow-up. Conclusions: Our study revealed favorable long-term clinical results following DES implantation using a systematic, rather simplified approach towards bifurcation stenting and using either a single or double stenting technique.
机译:目的:根据当代“现实世界”的实践,探讨在分叉病变中植入药物洗脱支架(DES)后的长期效果。背景:关于使用DES治疗的分叉病变患者的长期结果的信息有限。根据侧支直径和其口狭窄的严重程度,使用“临时”单支架技术或专用的两个支架策略,应用了系统的分叉病变管理方法。方法:411例接受DES分叉经皮冠状动脉介入治疗(PCI)的患者被纳入我们的前瞻性登记册。记录所有不良事件长达2年,并根据计划的PCI策略(例如,一个支架与两个支架技术)进行区分。结果:141例患者(占患者的35%)采用了计划中的两个支架策略。在260例患者中(65%),计划的治疗仅包括根据手术过程将主支支架置入支架,而将侧支支架“临时”置入支架。因此,有24名患者(9.2%)需要在侧支上额外放置支架以完成PCI。两组在1年和2年时的累积严重不良心脏事件发生率相似(1年和2年时分别为11.4%和14.8%,2年时分别为19.4%和25.7%,P = NS对彼此而言)。同样,在随访6、12和2年时,两组的死亡率,心脏死亡率,心肌梗塞,是否需要靶病变或靶血管血运重建或明确的支架血栓形成率没有差异。两组在随访期间经血管造影证实(即确定)的支架血栓形成率无差异。结论:我们的研究表明,DES植入术后使用系统的,相当简化的分叉支架置入方法,并使用单支架或双支架置入技术,可获得长期良好的临床效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号